Enhanced anticancer effect of ABT-737 in combination with naringenin on gastric cancer cells

被引:48
作者
Zhang, Haiyang [1 ]
Zhong, Xia [1 ]
Zhang, Xiao [2 ]
Shang, Deya [1 ]
Zhou, Yi [1 ]
Zhang, Chunqing [3 ]
机构
[1] Shandong Univ, Shandong Prov Hosp, Dept Emergency, Jinan 250021, Shandong, Peoples R China
[2] Shandong Ctr Dis Control & Prevent, Jinan 250014, Shandong, Peoples R China
[3] Shandong Univ, Shandong Prov Hosp, Dept Internal Med, Div Hepatogastroenterol, 324 Jingwu Weiqi Rd, Jinan 250021, Shandong, Peoples R China
关键词
ABT-737; naringenin; gastric cancer; anticancer; BH3 MIMETIC ABT-737; CARCINOMA CELLS; DOWN-REGULATION; APOPTOSIS; FLAVONOIDS; AKT; CARCINOGENESIS; MECHANISMS; SURVIVAL; LEUKEMIA;
D O I
10.3892/etm.2015.2912
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Gastric cancer is the second leading cause of cancer-associated mortality and is a frequently occurring cancer worldwide. Multiple drug resistance of gastric cancer cells leads to the poor prognosis. In addition, overexpression of anti-apoptotic protein B-cell lymphoma (Bcl)-2 have been demonstrated in various cancer cells and is closely associated with drug resistance and poor prognosis. Naringenin is a flavonoid that has antimutagenic and anticarcinogenic activities in numerous cancer types. In the present study, naringenin and a Bcl-2 inhibitor, ABT-737, were used to investigate their combinative anticancer effect in the SGC7901 gastric cancer cell line. The results revealed that naringenin and ABT-737 were able to inhibit SGC7901 cell growth and colony formation, alone or in combination. Furthermore, the combination of these drugs was found to further increase the cleavage of caspase-3 and poly ADP-ribose polymerase. Naringenin and ABT-737 also decreased Akt activation and increased p53 expression, suggesting the involvement of these pathways in the inhibition of gastric cell growth.
引用
收藏
页码:669 / 673
页数:5
相关论文
共 28 条
[1]   Induction of Apoptosis and Antiproliferative Activity of Naringenin in Human Epidermoid Carcinoma Cell through ROS Generation and Cell Cycle Arrest [J].
Ahamad, Md Sultan ;
Siddiqui, Sahabjada ;
Jafri, Asif ;
Ahmad, Sheeba ;
Afzal, Mohammad ;
Arshad, Md .
PLOS ONE, 2014, 9 (10)
[2]   Effect of Citrus Flavonoids, Naringin and Naringenin, on Metabolic Syndrome and Their Mechanisms of Action [J].
Alam, M. Ashraful ;
Subhan, Nusrat ;
Rahman, M. Mahbubur ;
Uddin, Shaikh J. ;
Reza, Hasan M. ;
Sarker, Satyajit D. .
ADVANCES IN NUTRITION, 2014, 5 (04) :404-417
[3]  
American Cancer Society, 2014, SURV RAT STOM CANC S
[4]   Naringenin (Citrus Flavonone) Induces Growth Inhibition, Cell Cycle Arrest and Apoptosis in Human Hepatocellular Carcinoma Cells [J].
Arul, Duraikannu ;
Subramanian, Perumal .
PATHOLOGY & ONCOLOGY RESEARCH, 2013, 19 (04) :763-770
[5]   ABT-737 is highly effective against molecular subgroups of multiple myeloma [J].
Bodet, Linda ;
Gomez-Bougie, Patricia ;
Touzeau, Cyrille ;
Dousset, Christelle ;
Descamps, Geraldine ;
Maiga, Sophie ;
Avet-Loiseau, Herve ;
Bataille, Regis ;
Moreau, Philippe ;
Le Gouill, Steven ;
Pellat-Deceunynck, Catherine ;
Amiot, Martine .
BLOOD, 2011, 118 (14) :3901-3910
[6]   ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells [J].
Cristofanon, S. ;
Fulda, S. .
CELL DEATH & DISEASE, 2012, 3 :e432-e432
[7]   Impact of naringenin on glycoprotein levels in N-methyl-N′-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats [J].
Ekambaram, Ganapathy ;
Rajendran, Peramaiyan ;
Devaraja, Rajasekaran ;
Muthuvel, Raju ;
Sakthisekaran, Dhanapal .
ANTI-CANCER DRUGS, 2008, 19 (09) :885-890
[8]   Naringenin reduces tumor size and weight lost in N-methyl-N′-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats [J].
Ekambaram, Ganapathy ;
Rajendran, Peramaiyan ;
Magesh, Venkataraman ;
Sakthisekaran, Dhanapal .
NUTRITION RESEARCH, 2008, 28 (02) :106-112
[9]   A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells [J].
Hatkevich, Talia ;
Ramos, Joseph ;
Santos-Sanchez, Idalys ;
Patel, Yashomati M. .
EXPERIMENTAL CELL RESEARCH, 2014, 327 (02) :331-339
[10]   Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy [J].
Kang, Min H. ;
Reynolds, C. Patrick .
CLINICAL CANCER RESEARCH, 2009, 15 (04) :1126-1132